Lv11
90 积分 2023-08-31 加入
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
6小时前
待确认
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
6小时前
已完结
Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies
4个月前
已完结
New Design Principles for Visual Acuity Letter Charts
4个月前
已完结
Guidelines for Proper Reporting of Clinical Significance, Including Minimal Clinically Important Difference, Patient Acceptable Symptomatic State, Substantial Clinical Benefit, and Maximal Outcome Improvement
8个月前
已完结
The Postvitrectomy Cataract
8个月前
已完结
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
8个月前
已完结
An Overview of Phase II Clinical Trial Designs with Biomarkers
8个月前
已完结
Dacomitinib in EGFR-mutant non-small-cell lung cancer with brain metastasis: a single-arm, phase II study
8个月前
已完结
皖公网安备34019202002308
